Cargando…
TREML2 Mutation Mediate Alzheimer’s Disease Risk by Altering Neuronal Degeneration
A coding missense mutation (rs3747742) in triggering receptor expressed on myeloid cell-like 2 (TREML2) has been recently proposed as an important protective factor against Alzheimer’s disease (AD). However, the link between TREML2 and AD pathology remains unclear. Therefore, we explored the associa...
Autores principales: | Song, Ya-Nan, Li, Jie-Qiong, Tan, Chen-Chen, Wang, Hui-Fu, Tan, Meng-Shan, Cao, Xi-Peng, Yu, Jin-Tai, Tan, Lan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529571/ https://www.ncbi.nlm.nih.gov/pubmed/31156362 http://dx.doi.org/10.3389/fnins.2019.00455 |
Ejemplares similares
-
A Candidate Regulatory Variant at the TREM Gene Cluster Confer Alzheimer’s Disease Risk by Modulating Both Amyloid-β Pathology and Neuronal Degeneration
por: Tian, Mei-Ling, et al.
Publicado: (2019) -
Missense variant in TREML2 protects against Alzheimer's disease
por: Benitez, Bruno A., et al.
Publicado: (2014) -
The Alzheimer’s disease-associated gene TREML2 modulates inflammation by regulating microglia polarization and NLRP3 inflammasome activation
por: Wang, Si-Yu, et al.
Publicado: (2022) -
TREML4 amplifies TLR7-mediated signaling during antiviral responses and autoimmunity
por: Ramirez-Ortiz, Zaida G., et al.
Publicado: (2015) -
Notoginsenoside R1–Induced Neuronal Repair in Models of Alzheimer Disease Is Associated With an Alteration in Neuronal Hyperexcitability, Which Is Regulated by Nav
por: Hu, Tao, et al.
Publicado: (2020)